antibody
  • Anti-hCCR8 mouse mAb

    Anti hCCR8 mouse monoclonal antibody

  • Anti-hCD38 mouse mAb

    Daratumumab (anti-CD38) is a recombinant monoclonal antibody against CD38. Daratumumab is an investigational cancer drug indicated for the treatment of adult patients with multiple myeloma.

  • Anti-mCD25 antibody

    Anti mCD25 mouse monoclonal antibody

  • Anti-mCCR8 mouse mAb

    Anti mCCR8 mouse monoclonal antibody

  • OPDIVO (nivolumab)

    OPDIVO (nivolumab) is a treatment for previously treated patients with advanced squamous non-small cell lung cancer (NSCLC).